Chiesi Global Rare Diseases Announces Support for Jeffrey Modell Foundation's Global Genetic Sequencing Initiative "Jeffrey's Insights"
prnewswire.com
news
2022-06-01 12:00:00

- Goal to test 10,000 people around the world suspected of a primary immunodeficiency - 
- Program available to more than 900 physicians at research, diagnostic and referral centers in the Jeffrey Modell Centers Network -
BOSTON, June 1, 2022 /PRNewswire/ -- Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research focused healthcare Group (Chiesi Group), today announced that it is joining with other pharmaceutical companies to support the Jeffrey Modell Foundation's initiative, "Jeffrey's Insights," a global genetic sequencing program.
